her2 positive
Showing 1 - 7 of 7
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Breast Cancer, HER2 Positive Trial in Netherlands (PTC+Pertuzumab, FEC-T+Pertuzumab)
Active, not recruiting
- Breast Cancer
- HER2 Positive
-
Alkmaar, Netherlands
- +32 more
Oct 11, 2022
Breast Cancer, HER2 Positive, Combination Chemo Trial in Chengdu (Pyrotinib Maleate Tablets, Albumin Paclitaxel, Trastuzumab)
Unknown status
- Breast Cancer
- +2 more
- Pyrotinib Maleate Tablets
- +2 more
-
Chengdu, Chengdu, Sichuan, China, ChinaWest China Hospital, Sichuan University
Nov 1, 2019
Metastatic Breast Cancer, HER2 Positive, First or Second Line Therapy Trial in Germany (Lapatinib and Capecitabine and
Terminated
- Metastatic Breast Cancer
- +3 more
- Lapatinib and Capecitabine and Vinorelbine
-
Ravensburg, Baden-Württemberg, Germany
- +10 more
Nov 20, 2014
Metastatic Breast Cancer, Brain Metastases, HER2 Positive Trial in Brussels (lapatinib and temozolomide)
Completed
- Metastatic Breast Cancer
- +2 more
- lapatinib and temozolomide
-
Brussels, BelgiumJules Bordet Institute
Sep 18, 2012
Breast Cancer, HER2 Positive Trial in Netherlands (paclitaxel, trastuzumab and carboplatin)
Completed
- Breast Cancer
- HER2 Positive
- paclitaxel, trastuzumab and carboplatin
-
Alkmaar, Netherlands
- +8 more
May 10, 2012